Cargando…
Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma
Epidermal growth factor receptor (EGFR) is a key molecule in the pathophysiology of oesophageal squamous cell carcinoma (OSCC). However, EGFR-targeted agents such as anti-EGFR antibody or tyrosine kinase inhibitors for OSCC have not demonstrated any clinical benefits. Recently, a novel chemotherapeu...
Autores principales: | Kikuchi, Osamu, Ohashi, Shinya, Horibe, Tomohisa, Kohno, Masayuki, Nakai, Yukie, Miyamoto, Shin’ichi, Chiba, Tsutomu, Muto, Manabu, Kawakami, Koji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796678/ https://www.ncbi.nlm.nih.gov/pubmed/26956916 http://dx.doi.org/10.1038/srep22452 |
Ejemplares similares
-
Protective role of ALDH2 against acetaldehyde-derived DNA damage in oesophageal squamous epithelium
por: Amanuma, Yusuke, et al.
Publicado: (2015) -
Distinct effects of EGFR inhibitors on epithelial- and mesenchymal-like esophageal squamous cell carcinoma cells
por: Yoshioka, Masahiro, et al.
Publicado: (2017) -
Preclinical Validation of Talaporfin Sodium-Mediated Photodynamic Therapy for Esophageal Squamous Cell Carcinoma
por: Ohashi, Shinya, et al.
Publicado: (2014) -
Oral administration of ferulic acid or ethyl ferulate attenuates retinal damage in sodium iodate-induced retinal degeneration mice
por: Kohno, Masayuki, et al.
Publicado: (2020) -
A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells
por: Kawamoto, Megumi, et al.
Publicado: (2011)